Vertex Pharmaceuticals shows promising signs despite a recent price drop. Strong fundamentals underscore its market position, ...

CRISPR Therapeutics advances with promising CTX310 data and key clinical milestones ahead. Click here to read an analysis of ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

Tech enhances subsurface imaging at Robinsons River Vortex Energy (CSE: VRTX; OTC: VTECF) announced all ambient noise tomography (ANT) sensors have been successfully deployed […] ...

Having backed Superluminal Medicines’ series A last year, Eli Lilly has now signed a $1.3 billion pact with the G ...

RTX Corporation has seen a significant reshuffle in its shareholder base. Barnett & Company Inc. slashed its stake in RTX by 29.1%, now holding shares worth about $2.2 million. This positions RTX as ...

Details of external meetings held between April 2021 and March 2022 by NHS England and NHS Improvement national directors with non-NHS/non-public sector organisations.